Clinicians Address the Resurgence of Syphilis in the United States
Syphilis diagnoses have continued to accelerate for the past few years due to COVID-19 pandemic-related restrictions at sexual health clinics.
Syphilis diagnoses have continued to accelerate for the past few years due to COVID-19 pandemic-related restrictions at sexual health clinics.
Substantial net benefit observed for syphilis screening of nonpregnant persons at increased risk for infection
In 2012, 332 babies were born infected with syphilis. In 2021, that number had climbed nearly sevenfold, to at least 2268.
A group of researchers provides guidance for diagnosing and treating syphilis, especially for pregnant women who can spread the infection to the fetus.
A substantial proportion of heterosexual syphilis transmission seems to be occurring among those who use drugs, especially methamphetamine.
Overall, 49% of pregnant women with syphilis did not report any of 15 risk factors.
Congenital syphilis up from 362 cases in 2013 to 918 in 2017, with 46.17% increase since 2016.
Screening results in decrease in incidence of congenital syphilis; no harms identified for penicillin.
Nearly 2.3 million total cases of chlamydia, gonorrhea, syphilis diagnosed in the United States in 2017.
Close to one-third of sexually active HIV-positive men who have sex with men (MSM) have not received syphilis screening in the past 12 months.